Berit X Carlson

Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.

Edward Kim, Chi-Chang Chen, S. Wisniewski, 2009, Pharmacoepidemiology and drug safety.

Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.

Hans H Stassen, Joseph R Calabrese, Stephen J Ganocy, 2011, Journal of affective disorders.